in vivo , single dose drug distribution studies of the fluorescence of doxorubicin indicate that in the heart after a cardiotoxic dose ( 20 mg/kg ) , myocardial concentrations were achieved which could cause 70-80 % inhibition of this phosphodiesterase enzyme .
C0018787
heart
C0027061
myocardial